NEW YORK, NY — As October marks Breast Cancer Awareness Month, the public conversation is frequently dominated by narratives of early detection, successful surgery, and the relief of being “cancer-free.” However, for a significant segment of the patient population, these messages can feel disconnected from their daily reality. On October 13, National Metastatic Breast Cancer (MBC) Awareness Day, the nonprofit organization METAvivor is cutting through the noise with a global initiative designed to bridge the gap between awareness and urgent medical action.
The #LightUpMBC campaign will see more than 325 landmarks across 20 countries, 195 cities, and all 50 U.S. states illuminate in the symbolic colors of metastatic breast cancer—teal, green, and pink. From the towering heights of New York’s One World Trade Center to the flowing waters of Niagara Falls and the historic streets of Inverness, Scotland, these lights serve as a visual testament to the 42,670 Americans projected to lose their lives to the disease in 2026.
Understanding the Invisible Struggle: What is MBC?
To understand the necessity of this global illumination, one must first understand the clinical reality of metastatic breast cancer. Often referred to as Stage 4, MBC occurs when cancer cells migrate from the breast to distant organs, most commonly the bones, liver, lungs, or brain.
Critically, even when the cancer spreads, it remains classified as breast cancer. It does not become "liver cancer" or "lung cancer"; it is breast cancer that has traveled. For many patients, this diagnosis comes as a shock—some are diagnosed at Stage 4 from the outset, while others find their cancer has returned months, years, or even decades after completing successful treatment for early-stage disease.
The medical landscape for these patients is defined by indefinite treatment. Because there is currently no cure, the primary goal of modern medicine is to manage the disease, extend life, and maintain a high quality of life. However, cancer is a formidable opponent; it often develops resistance to therapeutic agents, forcing patients to cycle through new, increasingly complex treatment plans. With approximately 117 people dying from the disease every single day in the United States, the urgency for breakthrough research has never been higher.
A Chronology of Advocacy: From a Local Wish to a Global Beacon
The journey of #LightUpMBC is a testament to the power of grassroots advocacy. The campaign was born from the personal grief and determined spirit of Laura Inahara, who sought to honor her best friend, Jessica Moore.
The Evolution of the Movement:
- 2017: The movement began on a smaller, more intimate scale. Portsmouth’s Memorial Bridge in New Hampshire became the first landmark to illuminate in honor of those living with MBC. Jessica Moore’s original dream was modest: to see one local landmark shine for the cause.
- 2018–2024: As word of the campaign spread through patient support networks, it gained rapid momentum. What started as a single bridge expanded into a national endeavor, incorporating social media strategies that allowed families across the country to participate by sharing images of their own local landmarks.
- 2025: The campaign achieved international recognition, cementing partnerships with historical sites and major city infrastructure worldwide.
- 2026: The current year marks the most expansive iteration of the project to date, featuring over 325 landmarks. The campaign has now raised over $2.7 million, directly funding research grants through METAvivor.
Supporting Data: Why Research is the Only Path Forward
METAvivor stands apart in the nonprofit sector because it exclusively funds Stage 4 metastatic breast cancer research. Unlike organizations that split their funding across early-stage screening, education, and support services, METAvivor focuses its entire financial engine on the "terminal" side of the spectrum.
The organization’s methodology is rooted in a rigorous, two-tier review process:
- Scientific Peer Review: Every grant proposal is vetted by leading oncologists and researchers to ensure scientific validity and potential for clinical impact.
- Patient Advocate Review: Each project is reviewed by patients living with MBC. This ensures that the research being funded aligns with the actual needs and quality-of-life priorities of the community.
The necessity of this focus is underscored by the current statistics. While early detection remains vital for general breast cancer outcomes, it offers little comfort to those whose cancer has already disseminated. Research into immunotherapy, targeted drug delivery, and overcoming drug resistance is the only pathway to turning a terminal diagnosis into a chronic, survivable condition.
Official Responses: Voices from the Frontlines
The leadership of METAvivor represents the very community they serve. Dr. Kelly Shanahan, the organization’s Board President, speaks from a place of lived experience. Diagnosed in 2013, Dr. Shanahan has defied the odds, a reality she attributes to the continuous evolution of cancer research.
“When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan remarked. “My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community.”
The founder of the campaign, Laura Inahara, emphasizes that the lights are not just for those who have passed, but for the living as well. “Jessica hoped to illuminate one local landmark,” Inahara noted. “Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research.”
The #LightUpMBC Live Experience
The centerpiece of the awareness day is the #LightUpMBC Live broadcast, a high-production event designed to educate and inspire. Airing on Tuesday, October 13, at 8 p.m. ET / 5 p.m. PT, the event will be hosted by Tami Eagle Bowling—a veteran advocate who has lived with MBC for 11 years—and Broadway performer and breast cancer survivor Kara Lindsay.
The broadcast is designed to be accessible to a global audience, streaming for free via the METAvivor YouTube channel, Facebook Live, and the digital platform LiveOne. The program promises a blend of:
- Patient Narratives: Real-time stories shared from various illuminated landmarks, providing a face to the statistics.
- Scientific Insights: Brief, accessible segments explaining the current frontier of cancer research and what these funds actually achieve.
- Artistic Tributes: Musical performances from acclaimed artists including two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, and singer-songwriter Cassandra Kubinski.
Implications: Transforming the Future of Care
The implications of the #LightUpMBC campaign extend far beyond the aesthetic of glowing buildings. By demanding a seat at the table for Stage 4 patients, the movement is forcing a cultural shift in how we talk about breast cancer.
For the average citizen, the campaign offers a clear, actionable way to support the cause. Beyond donating, the organizers are encouraging the public to engage with the movement by photographing the illuminated landmarks and sharing them on social media with the tags #LightUpMBC and #METAvivor. This digital footprint serves to normalize the conversation around metastatic disease, removing the stigma and silence that often surround terminal diagnoses.
Ultimately, the goal of METAvivor is to render itself obsolete by achieving its mission: to transform metastatic breast cancer into a condition that people can live with for decades, rather than months. Every dollar raised through this campaign is a step toward that reality.
How to Get Involved:
- Watch: Tune into the #LightUpMBC Live stream at 8 p.m. ET on October 13.
- Engage: Visit www.lightupmbc.org to find a map of participating landmarks in your area.
- Contribute: Consider donating to the METAvivor research fund, where 100% of net proceeds from the campaign go directly toward scientific grants.
As the sun sets on October 13, the world will glow in teal, green, and pink. It is a visual promise that while the disease is persistent, the community fighting it is even more so. Through science, advocacy, and the simple act of shining a light, the path to a future where metastatic breast cancer is no longer a death sentence becomes that much clearer.
About the Author
